Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population

  1. Ariel Israel  Is a corresponding author
  2. Alejandro A Schäffer
  3. Assi Cicurel
  4. Ilan Feldhamer
  5. Ameer Tal
  6. Kuoyuan Cheng
  7. Sanju Sinha
  8. Eyal Schiff
  9. Gil Lavie
  10. Eytan Ruppin  Is a corresponding author
  1. Clalit Health Services, Israel
  2. National Institutes of Health, United States
  3. Sheba Medical Center, Israel
  4. Tel-Aviv University, Israel
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/68165/elife-68165-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ariel Israel
  2. Alejandro A Schäffer
  3. Assi Cicurel
  4. Ilan Feldhamer
  5. Ameer Tal
  6. Kuoyuan Cheng
  7. Sanju Sinha
  8. Eyal Schiff
  9. Gil Lavie
  10. Eytan Ruppin
(2021)
Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
eLife 10:e68165.
https://doi.org/10.7554/eLife.68165